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ABSTRACT
Purpose: The roles of gut microbiota on the natural course of atopic dermatitis (AD) are 
not yet fully understood. We investigated whether the composition and function of gut 
microbiota and short-chain fatty acids (SCFAs) at 6 months of age could affect the natural 
course of AD up to 24 months in early childhood.
Methods: Fecal samples from 132 infants were analyzed using pyrosequencing, including 
84 healthy controls, 22 transient AD and 26 persistent AD subjects from the Cohort for 
Childhood Origin of Asthma and Allergic Diseases (COCOA) birth cohort. The functional 
profile of the gut microbiome was analyzed by whole-metagenome sequencing. SCFAs were 
measured using gas chromatography-mass spectrometry.
Results: Low levels of Streptococcus and high amounts of Akkermansia were evident in transient 
AD cases, and low Clostridium, Akkermansia and high Streptococcus were found in children with 
persistent AD. The relative abundance of Streptococcus positively correlated with scoring of AD 
(SCORAD) score, whereas that of Clostridium negatively correlated with SCORAD score. The 
persistent AD group showed decreased gut microbial functional genes related to oxidative 
phosphorylation compared with healthy controls. Butyrate and valerate levels were lower in 
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transient AD infants compared with healthy and persistent AD infants.
Conclusions: Compositions, functions and metabolites of the early gut microbiome are 
related to natural courses of AD in infants.
Keywords: Dermatitis, atopic; gastrointestinal microbiome; metagenome; infant; 
metabolomics
INTRODUCTION
Allergic diseases have shown a dramatically increased prevalence over the last few decades 
and recent research points to a central role of the microbiota.1 It is well established that the 
gut microbiome can modulate the immune response, from cellular development to organ 
and tissue formation2 exerting its effects through multiple interactions with both the innate 
and acquired immune system. In the late 1980s, the “hygiene-hypothesis” was proposed,3 
in which factors in the environment and nutrition can cause a dysbiosis of the skin, gut, 
or lung microbiome, inducing qualitative and quantitative changes in its composition and 
metabolic activity.4
Atopic dermatitis (AD) affects 17%–24% of the pediatric population. It develops during the 
first 6 months of life in 45% of children and by 5 years of age in 85% of the affected subjects.5 
Contrary to the prior concepts of outgrowing AD, it is now known that only half of affected 
children show resolution of this disease in adulthood, indicating its chronic characteristics.6 
The persistence of AD in early childhood was found to be one of the most important risk 
factors for adolescent AD and atopic march.7,8 The early life decisive factor determining the 
remission or persistence of AD is not yet known.
In patients with AD, the proportions of Escherichia coli, Staphylococcus aureus and Clostridia, 
including Clostridium difficile, in the gut microbiome are higher than in healthy controls, 
whereas those of Bacteroidetes, Bifidobacterium and Bacteroides are lower.9,10 In our previous 
study, we found that a decrease in microbial genes required for the development of the host 
immune system through the reduction of mucin-degrading bacterial (Akkermansia muciniphila, 
Ruminococcus gnavus, and Lachnospiraceae bacterium 2_1_58FAA) colonization of the gut was 
significantly associated with stunted immune development in AD infants. Most of the 
previous studies in this regard have reported that the gut microbiome is associated with the 
development of AD.11 However, the relationship between the natural course of AD and gut 
microbiota has not yet been described.
Short-chain fatty acids (SCFAs), such as butyrate, propionate, and acetate, are primary 
energy sources with anti-inflammatory and immunomodulatory effects, regardless of 
their interactions with gut epithelial barrier.12 Alterations of gut microbiome affect the 
balance of immune system via the production of metabolites, which can cause an inflamed 
microenvironment with the presence of specific microbiome in the gut.13 A recent study 
showed that lower levels stool SCFAs were associated with the development of AD in 
infants.14 Butyrate-producing bacteria, such as Coprococcus eutactus in the gut,15 are increased 
in infants with mild AD or healthy infants than in those with severe AD.16 Therefore, 
concurrent considerations on the composition of gut microbiota with their functions as 
well as the related metabolites are needed to identify the effect of gut microbiota on the 
pathogenesis of AD.
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In our present study, we further investigated the role of the gut microbiome in determining 
the natural course of AD. Moreover, because AD develops during an early stage around first 6 
months, so we need search for early microbiome associated markers for prediction of AD. We 
thus analyzed whether the composition and function of the gut microbiota and stool SCFA at 
6 months of age could affect the course of AD in early childhood.
MATERIALS AND METHODS
Subjects and study design
The study population consisted of 132 Korean infants involved in the Cohort for Childhood 
Origin of Asthma and Allergic Diseases (COCOA), which was a previously established general 
population-based birth cohort.17 In COCOA, women in the third trimester of pregnancy 
were recruited from 5 tertiary hospitals and 8 public health centers for prenatal care; all 
centers are located in Seoul, Korea. Recruitment took place between August 2007 and 
August 2015. A woman was recruited if she 1) lacked high-risk conditions that could affect 
the development of allergic diseases in the child (e.g., diabetes, preeclampsia, anemia, and 
severe infection); 2) planned to deliver at an affiliated medical center; and 3) was a resident of 
Seoul. The eligibility of the baby was determined soon after delivery by collaborative efforts 
of obstetricians and pediatricians. Babies were excluded at birth if 1) their gestational age 
was less than 37 weeks or 2) they had any major congenital anomalies or birth asphyxia that 
required oxygen supplementation.
Gut microbiota was prospectively analyzed from 84 healthy infants, and those with transient 
AD (n = 22) and persistent AD (n = 26) at 6 months of age in available fecal samples of 
COCOA. The transient AD phenotype was defined as a development of AD at 6 months of age 
and remission of this condition by 1 year of age. Persistent AD was defined as a development 
of AD at 6 months of age with persistent symptoms at 2 years of age by a pediatric allergy 
specialist. The baseline characteristics of the subjects are presented in Table. A diagnosis of 
AD was based on the Hanifin and Rajka's criteria18 and the control group (subjects without 
AD) was defined by a lack of history of any visible signs of skin eczema indicative of AD 
and non-use of steroid treatment for the skin, which was confirmed by a pediatric allergy 
specialist. The severity of AD using the scoring of AD (SCORAD) index was simultaneously 
assessed at the time of fecal collection at 6 months of age from infants who had received no 
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Table. Characteristics of the study population
Characteristics Control Transient AD Persistent AD Trend P value
Number 84 22 26 -
Sex, male/female 45/39 14/8 13/13 0.937
Parental history of allergic disease, positive/total (%) 32/83 (38.6) 10/22 (45.5) 19/26 (73.1) 0.003
Total IgE 38.02 ± 6.86 93.89 ± 48.19 188.44 ± 113.50 0.013
Specific IgE to egg 0.57 ± 0.27 3.40 ± 3.02 5.11 ± 2.34 0.005
Specific IgE to milk 0.29 ± 0.10 0.39 ± 0.15 0.97 ± 0.37 0.012
Eosinophil (%) 2.90 ± 0.20 4.39 ± 0.83 6.34 ± 0.94 < 0.001
SCORAD of 6 months ND 15.17 ± 1.72 27.48 ± 3.19 0.004*
Food sensitization (≥ 0.35 IU/mL, specific IgE) 14/76 (18.4) 8/17 (47.1) 16/22 (72.7) < 0.001
Feeding type, breast/formula/mixed 25/10/47 4/0/16 13/1/12 0.053
Delivery type, vaginally/caesarean 58/25 16/6 20/6 0.323
Probiotics, positive/total (%) 5/81 (6.2) 1/22 (4.5) 8/26 (30.8) 0.001
Values are presented as number (%) and mean ± standard error. No history of antibiotic use before sampling.
AD, atopic dermatitis; IgE, immunoglobulin E; ND, not done; SCORAD, scoring of atopic dermatitis.
*Mann-Whitney test.
prior antibiotics for confirmed the microbiome marker before antibiotics use, because the 
effects of antibiotics on microbiome profiles could be especially significant.
This study was approved by the Institutional Review Boards (IRBs) of Asan Medical Center 
(IRB No. 2008-0616), Samsung Medical Center (IRB No. 2009-02-021), Severance Hospital 
(IRB No. 4-2008-0588), CHA Medical Center (IRB No. 2010-010) and Seoul National 
University Hospital (IRB No. H-1401-086-550). The Ethics Committee of Asan Medical Center 
approved this study, and all participants or their parents (in cases in which the participants 
were < 17 years old) provided written informed consent.
Genomic DNA extraction and 16s rRNA pyrosequencing
To control for external factors that might alter the composition of the microbiome, we only 
included subjects with no history of antibiotic use prior to stool sampling. Parents collected 
fecal samples from diapers at 6 months of age and immediately placed them at −20°C. Each 
center transported the diapers in ice-boxes to Asan Medical Center within 4 hours, which 
were immediately stored at −80°C before being processed for DNA extraction. Metagenomic 
DNA was isolated from these fecal samples using a Power Microbiome RNA/DNA Isolation 
kit (MO BIO/Qiagen, Carlsbad, CA, USA) in accordance with the manufacturer's instructions. 
DNA was eluted in 50 µL of elution buffer and stored at −20°C prior to use. Genomic DNA 
concentrations and purity were assessed by spectrophotometry. After removing humic 
acid with the Power-Clean® DNA Clean-Up Kit (MO BIO Laboratories, Carlsbad, CA, USA), 
polymerase chain reaction (PCR) was performed for each fecal specimen to amplify the 
16S rRNA gene targeting V1-V3 of the variable region using barcoded primers. Sequencing 
was performed on a Roche/454 FLX Titanium system (Roche, Mannheim, Germany) 
according to the manufacturer's instructions. The total amount of bacteria in fecal samples 
was determined by using quantitative real-time PCR for 16S rRNA genes. More detailed 
procedures of this pyrosequencing method are provided in our previous study.11
Whole metagenome sequencing of functional genes
Forty-eight healthy controls 12 transient AD subjects and 16 persistent AD subjects were 
used for whole metagenome sequencing, because only 76 subjects were sufficient in fecal 
volume to perform for whole metagenome sequencing. The baseline characteristics of 
these subjects are provided in Supplementary Table. Metagenomic DNA from selected 
samples was fragmented using a Covaris M220 sonicator (Covaris, Inc., Woburn, MA, 
USA), and metagenomic libraries were prepared using the TruSeq DNA sample preparation 
kit according to the manufacturer's instructions (Illumina, San Diego, CA, USA). The size 
of the prepared libraries was confirmed using a Bioanalyzer 2100 (Agilent Technologies, 
Santa Clara, CA, USA). Equimolar concentrations of each library (2 nM) were calculated 
by quantitative real-time PCR using the CFX 96 Real-Time System (Bio-Rad, Hercules, CA, 
USA) with Illumina adapter sequence primers. Sequencing was performed using the Illumina 
HiSeq 2500 system (250 bp paired ends).
Sequences from the HiSeq 2500 sequencer were trimmed using the Nesoni clip tool within 
the Nesoni high-throughput sequencing data analysis toolset (ver. 0.127, http://www.
vicbioinformatics.com/software.nesoni.shtml) to remove the Illumina adapter sequences 
and sequences with short read lengths (< 150 bp in each pair) and low Q scores (< 15). 
Contaminating human genes were removed using BBMap (http://sourceforge.net/project/
bbmap) by mapping to a reference human genome. Functional profiling of metagenomic 
sequences was performed using HUMAnN2, which uses pan-genome mapping sequences 
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to functionally annotate species pangenomes determined by taxonomic profiling from 
MetaPhlAn2. The resulting functional profiles were obtained in terms of gene family 
abundance at the community level in reads per kilobase to normalize for gene length. 
The resulting UniRef50 IDs were converted to the KEGG Orthology (KO) based on the 
matching K numbers (http://www.genome.jp/kegg/kegg2.html). Converted KO categories 
were compared among the groups. More detailed procedures of this whole metagenome 
sequencing method are provided in our previous study.11
Measurement of the total serum immunoglobulin E (IgE) and eosinophil
The total serum IgE levels and percentage of blood eosinophils were measured at 1 year of 
age. The total serum IgE levels were measured using the ImmunoCAP-CAP 1000 system 
(Phadia AB, Uppsala, Sweden). Concentrations of at least 0.35 kU/L (corresponding to CAP 
class 1) were considered positive. Atopy was defined as a ≥1 positive response. Eosinophils 
were counted using an automatic blood-cell counter (XE-100; Sysmex Co., Kobe, Japan).
Measurement of SCFAs
SCFAs as acetate, propionate, butyrate, and valerate, are prospectively analyzed in fecal 
samples from healthy infants (n = 33), and those with transient AD (n = 12) and persistent 
AD (n = 12) at 6 months of age. Briefly, fecal samples of 200 mg were diluted at ratio 1:4 
(w/v) in deionized water, and then these samples were vigorously vortexed and upper 
layer supernatants were collected after centrifugation. Supernatants were extracted by 
shaking with internal standard solution, 20 μL of 0.6 N HCl and 2 mL of diethyl ether. 
After centrifugation, the upper layer supernatant was collected and completely dried under 
vacuum. The sample was reconstituted with 100 μL acetonitrile. SCFAs were analyzed with 
GC-MS (7890A/5975A [Agilent]), and HP-5 MS 30 m × 250 μm × 0.25-μm column (Agilent 
19091S-433).
Statistical analysis
Differences between the characteristics of our 3 study groups were analyzed using the linear 
regression test for trend. Alpha- and beta-diversity analyzed using Calypso, an online tool 
(found at http://cgenome.net/calypso/). Differences in bacterial alpha diversity (richness; 
operational taxonomic units [OTUs] and Shannon index) among the studies were evaluated 
using analysis of variance. Significantly different microbial members between the clusters 
were analyzed again by the linear discriminant analysis effect size (LEfSe). The statistical 
significance was defined as an alpha level of 0.05 and an effect size threshold of 4 were used 
to identify differences in levels of different taxa between the groups.
Comparisons of the relative abundance of gut microbiota between the 2 groups were performed 
using the Mann-Whitney U test. Correlations between the total IgE, eosinophils (%) at 1 year of 
age, SCORAD at 6 months of age and relative abundance of gut microbiota were analyzed using 
the Spearman correlation test. Differences in the gut composition among the 3 groups were 
analyzed using the Kruskal-Wallis test and the Mann-Whitney U test.
Significantly different KO categories among the groups were identified using the Kruskal-Wallis 
test and the Mann-Whitney U test. Significant pathways had a P value < 0.05. Furthermore, 
differences between bacterial taxa among the groups were tested by the Kruskal-Wallis test. 
The Kruskal-Wallis test was used to compare the frequency of each taxa among groups. After 
identifying taxa with significantly different frequencies among the groups, corrections were 
made using the Benjamini-Hochberg False Discovery Rate multiple testing correction.11,19 All 
326https://e-aair.org https://doi.org/10.4168/aair.2020.12.2.322
Imbalance of Guts strains to the Natural Course of Atopic Dermatitis
statistical analyses were conducted using SPSS statistical software, version 24.0 (SPSS Inc, 
Chicago, IL, USA), with P < 0.05 considered to indicate statistical significance.
RESULTS
Characteristics of the study subjects
Detailed data regarding the characteristics of the study population are summarized in Table. 
We divided our study population into healthy controls, and subjects with either a transient 
or persistent AD phenotype. A parental history of allergic disease and food sensitization 
were higher in the persistent AD group among the 3 phenotypes (P = 0.003 and P < 0.001, 
respectively). Specific IgE (egg and milk IgE) and percentage of eosinophil were highest in 
the persistent AD among the 3 phenotypes (P < 0.005, P < 0.012 and P < 0.001, respectively). 
The SCORAD at 6 months of age was higher in the persistent AD (mean ± standard error; 
27.48 ± 3.19; P = 0.004) compared to the transient AD (15.17 ± 1.72). The total IgE levels were 
more increased in the persistent AD subjects than in the healthy control and transient AD 
groups (P = 0.013).
Comparison of the diversity and composition of the gut microbiota
A total of 2,507,762 high quality reads were analyzed from fecal samples of matching selected 
infants in this study (n = 132). We assessed the alpha-diversity to examine the similarity of 
the 3 sets of samples. Alpha diversity results indicated that the richness (OTUs) and Shannon 
index did not differ among the 3 groups (P > 0.05; Fig. 1A and B). Comparing the beta-
diversity of the different 3 groups did not show any significance (Fig. 1C).
The composition of the gut microbiota among our 3 study groups was then examined at the 
phylum and genus levels (Fig. 2A and B). At the phylum level, Actinobacteria, Firmicutes and 
Proteobacteria were predominant among the 3 phenotypes. The proportion of Actinobacteria was 
higher in the transient AD subjects than the healthy controls (P = 0.029, Fig. 2A). However, 
the difference between the Firmicutes and Proteobacteria was not significant among the 3 groups 
(P > 0.05; Fig. 2A).
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Fig. 1. Bacterial alpha and beta-diversity within the gut microbiota of the infant subjects. (A, B) Dotplots of richness (OTUs) and Shannon index of alpha diversity 
in the gut microbiota were compared among the study groups. (C) The beta-diversity of microbiota was compared using the PCoA plot based on unweighted 
UniFrac distances. 
OTU, operational taxonomic unit; PCoA, principal coordinates analysis; ANOVA, analysis of variance; AD, atopic dermatitis.
We further identified differences in the microbiota composition at the genus level. Analysis 
using LEfSe revealed significant abundance differentials between the AD phenotypes with 
effect size threshold of > 4 (P < 0.05, Supplementary Fig. S1). Streptococcus was significantly 
higher in persistent AD (7.93% ± 2.47%) compared with the healthy control and transient AD 
(3.59% ± 0.91% in controls, P = 0.012 and 1.09% ± 0.39% in transient AD, P = 0.004; Fig. 2B 
and C). The proportion of Clostridium was significantly higher in controls (6.45% ± 1.24%) 
compared with the persistent AD (1.12% ± 0.74% in persistent AD, P = 0.013, Fig. 2B and C), 
but was not different between the healthy control and transient AD (6.97% ± 2.93% in transient 
AD, P > 0.05, Fig. 2C), or between the transient and persistent AD (P > 0.05, Fig. 2C). Further, 
Akkermansia species were at lower levels in the persistent AD infants (0.01% ± 0.01%) compared 
with transient AD infants (5.61 ± 3.98, P = 0.019, Fig. 2B and C). Moreover, the composition 
of Akkermansia in transient AD infants was higher than the healthy controls (3.27% ± 1.18%, 
P = 0.049; Fig. 2B and C). However, the Akkermansia abundance was not different between 
the healthy control and persistent AD groups (P > 0.05, Fig. 2C). Samples dominated 
by Firmicutes were separated according to the dominance of Streptococcus and Clostridium. 
Although the E. coli abundance was higher in all 3 phenotypes, the differences in these 
bacterial compositions were not significant (P > 0.05; Fig. 2B). Moreover, Bifidobacterium was 
higher in the transient AD subjects than in the healthy controls (P = 0.027, Fig. 2B).
328https://e-aair.org https://doi.org/10.4168/aair.2020.12.2.322





















































































































































































Fig. 2. Phylum and genus compositions of the gut microbiota of the infant subjects. Comparison of bacterial (A) phylum and (B) genus in each group expressed 
as the mean diameter ± standard error with the P value. Orange denotes the healthy control group, red denotes the transient AD group, and gray denotes 
the persistent AD group. (C) Comparison of the Streptococcus, Clostridium and Akkermansia compositions within the gut microbiota. The significance of any 
differences between groups was tested using the Mann-Whitney U test. 
AD, atopic dermatitis. 
*P < 0.05; †P < 0.01.
Correlation between the total IgE, SCORAD, and eosinophil (%) and the gut 
microbiota composition
To investigate the role of Streptococcus and Clostridium in clinical parameters of AD, we analyzed 
the relationship between the total IgE (IU/mL), SCORAD, eosinophil level (%) and the relative 
abundance of Streptococcus and Clostridium in the AD groups (Fig. 3). Relative abundance of 
Streptococcus in AD was positively correlated with the SCORAD (rho = 0.493, P = 0.001; Fig. 3A), 
but not with the total IgE or eosinophil (%) (P > 0.05; Fig. 3B and C). In addition, Clostridium 
abundance was negatively correlated with SCORAD (rho = −0.651, P = 0.003; Fig. 3D), but not 
correlated with the total IgE or eosinophil (%) (P > 0.05; Fig. 3E and F). There was no correlation 
between Akkermansia and the SCORAD, eosinophil (%) or total IgE levels (data not shown).
Different functional profiles in the gut microbiota in accordance with AD 
persistence
Functional gene differences among the study groups were compared using KO categories 
after the removal of human and plant gene sequences. The whole-metagenome analysis was 
identified based on 16S rRNA gene sequencing. Significantly different KO categories were 
selected using a P value < 0.05. We thereby identified 6 pathways of first KO categories including 
44 pathways of second KO categories (Supplementary Fig. S2). We found that immune system 
and development pathway genes were decreased in the persistent AD compared to the healthy 
controls (P < 0.05; Supplementary Fig. S2B) and that metabolism of cofactors and vitamin 
pathway genes were increased in the persistent AD compared to the transient AD (P < 0.05; 
Supplementary Fig. S2). We next confirmed the 3rd KO categories among the groups. The 
relative abundance of genes associated with oxidative phosphorylation was decreased in 
the persistent AD compared to the healthy controls (P = 0.001; Fig. 4). A. muciniphila weakly 
contributed to differences in the expression of oxidative phosphorylation genes between 
persistent AD and healthy controls (P = 0.094).
Comparison of SCFAs levels according to the persistence of AD
Butyrate and valerate levels were lower in infants with transient AD than in healthy controls 
(P = 0.011 and P = 0.004, respectively; Fig. 5C and D) and those in the persistent AD group 
(P = 0.020 and P = 0.008, respectively; Fig. 5C and D). Propionate levels were weakly lower 
in the transient AD group compared with healthy controls (P = 0.051, Fig. 5B). However, 
there were no statistical differences in the acetate and propionate levels among the 3 groups 
(P > 0.05; Fig. 5A).
DISCUSSION
We compared the composition and functional genes of the gut microbiome in infants at 6 
months of age according to the persistence of AD up to 2 years of age. In subjects with the 
persistent AD phenotype, the proportion of Streptococcus was higher and that of Clostridium was 
lower compared to healthy controls. The proportion of Akkermansia was higher in children 
with the transient AD phenotype than in the controls or persistent AD cases. The relative 
abundance of Streptococcus was positively associated with the SCORAD and that of Clostridium 
was negatively associated with this value. These results suggest that the balance of gut 
Streptococcus, Clostridium and Akkermansia in early life is associated with the natural course of 
AD. Moreover, decreased oxidative phosphorylation related with A. muciniphila in the gut 
microbiota was associated with the persistence of AD. Butyrate and valerate levels in SCFAs 
were lower in infants with transient AD group than healthy controls and those in the persistent 
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AD groups. potential model for gut microbiome composition, their functional gene and 
metabolites in the natural course of AD by the present study is summarized in Fig. 6.
331https://e-aair.org https://doi.org/10.4168/aair.2020.12.2.322






















































































































Fig. 5. Comparison of SCFAs between 3 groups. Comparison of (A) acetate, (B) propionate, (C) butyrate, (D) 
valerate between among the groups *P < 0.01; †P < 0.05; ‡P < 0.01. 




























































Fig. 4. Comparison of the metabolic pathways in the infant gut microbiota using metagenome analysis. Comparison of the functional genes related to oxidative 
phosphorylation and their contributing species among the study groups. Black arrow denotes Akkermansia muciniphila, P = 0.094. 
AD, atopic dermatitis. 
*P = 0.001.
Most studies to date have reported on the relationship between the composition and diversity of 
gut microbiota and the development of AD.15 Early-life microbial dysbiosis in the gut has been 
linked to the development of AD in previous studies.9,10,16 It has been reported that diversity 
of gut microbiota during the first month of life is associated with subsequent AD,9 whereas 
other studies show the no association between the diversity of gut microbiota and AD.15,20 A 
high abundance of butyrate-producing bacteria including Roseburia intestinalis, C. eutactus and 
Anaerostipes caccae in the gut in 6-month-old infants with atopic eczema alleviates the symptoms 
of this disease.16 The highest risk group for childhood atopy and asthma are reported to have 
lower Faecalibacterium abundance in the neonatal gut microbiota.21 LEfSe analysis in our current 
study revealed a significant differential abundance of gut microbiota among children with AD 
(effect size threshold > 4, P < 0.05; Supplementary Fig. S1); however, most gut microbiota are 
less abundant (< 5%) in infants. Although our current analysis and previous studies indicate 
the significance of gut microbiota dysbiosis in AD onset, the mechanisms by which specific 
microbial alterations regulate the inflammation underlying AD remain unknown.
In a recent study, colonization by gut Clostridium in infancy was associated with wheeze, 
asthma and eczema.9,22,23 In contrast, the high abundance of Clostridia in infancy negatively 
correlated with blood eosinophils,10 and similar to our current results, its prevalence in the 
gut microbiota of allergic infants, i.e., who had a positive skin prick test, was lower than the 
healthy controls.24 Eosinophils regulate a variety of pathways in immune homeostasis, and 
play an important role in the development of AD.25 When Clostridium colonizes in the gut 
of mouse model, serum IgE is decreased in ovalbumin-alum treated mice.26 The results of 
these previous studies support our current findings showing an association of Clostridium 
with the AD persistence and severity. The increase in gut Streptococcus may thus be linked to 
not only the development of AD but also its severity from this study. However, association 
between Streptococcus in the gut and AD has not been elucidated previously. The aerobic 
and the facultative anaerobic bacteria, including pathogenic bacteria such as Enterococcus, 
Streptococcus and E. coli are subdominant bacteria in the gut.27 These bacteria facilitate the 
growth of anaerobic bacteria such as Bifidobacterium, Clostridium and Bacteroides by consuming 
the intestinal oxygen and aerobes gradually decrease.28 Eventually, 99.9% of gut microbiota 
was composed of anaerobic bacteria in the normal gut environment. In the present study, the 
relative abundance of Streptococcus at 6-month of age was significantly higher in the persistent 
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Fig. 6. Potential model for compositions, functions and metabolites of the gut microbiome according to the 
natural course of AD. 
AD, atopic dermatitis; SCFA, short chain fatty acid.
AD group than that in the healthy controls and the transient AD group. This finding suggests 
that late establishment of anaerobic bacteria in association with Streptococcus in infants aged 
6 months old may lead to imbalance of gut microbiota, which may be associated with the 
persistence of AD. Hence, even though a direct link between gut Streptococcus and AD is yet 
to be determined, it may be mediated through local or systemic inflammatory cytokines. 
Further studies are necessary to investigate the role of gut Streptococcus in infancy. In addition, 
the mucin-degrading bacteria, including A. muciniphila, contributes to the normalization of 
gut colonization by providing the degraded mucin for energy and a source of nutrients.11,29 
High abundance of Akkermansia in the transient AD group may help the growth of anaerobe 
and thereby affect the remission of AD.
A. muciniphila, which was found to be a beneficial gut bacterium and maintain the integrity 
of the gut barrier,11,30 is known to be decreased in individuals with allergic diseases such as 
AD and food allergy11,31 as well as patients with other autoimmune diseases such as diabetes 
type 2.32 A. muciniphila is known to exert negative effects of IFN-γ on glucose metabolism in 
the intestine33 and induce the pro- and anti-cytokine responses of human peripheral blood 
mononuclear cells.34 Previous reports have indicated the association of A. muciniphila with the 
alteration of functional genes related to host immune development in AD.11 These previous 
studies support our current findings that higher relative abundance of gut Akkermansia 
promotes the availability of nutrients for other microbiota and alters the immune response 
that may affect AD remission.
Recent metagenome shotgun analysis has also revealed the relationship between gut 
microbiota function and AD.11,35 One recent study reported that differences in functional 
genes related to host immune development in the gut microbiota were associated with AD 
in 6-month-old infants,11 and another reported that the dysbiosis of Faecalibacterium prausnitzii 
can lead to an increased risk of AD by reducing butyrate and propionate.35 However, there has 
been no prior study showing that an imbalance in the infant gut microbiota affects the AD 
phenotype and that the natural course of the disease in early life is impacted by differences in 
the gut metagenome. Regulatory T cells are dependent on oxidative phosphorylation for their 
energy tolerance, and cytotoxic and effector T cells are dependent on glycolysis for not only 
their proliferation but also the production of cytokines.36 These energy metabolic pathways 
are known to affect the health of the microbial community in the human gut.37 Our current 
results thus suggest that reduced oxidative phosphorylation is associated with the alteration 
in regulatory T cells and energy metabolism, which might subsequently affect the persistence 
of the AD phenotype.
SCFAs serve as an important energy source that regulates the inflammatory and immune 
response and energy metabolism.38,39 SCFAs regulate metabolic sensors to stimulate oxidative 
phosphorylation, which produces energy in B cells and mitochondria.40,41 In addition, 
acetate can cause suppression of allergic airway diseases by enhancing the numbers and 
function of regulatory T cells.42 The G protein-coupled receptors (GPCRs) as a regulator of 
energy balance was stimulated by SCFAs and the induced GPCRs affect the inhabitant of 
gut microbiota.43,44 A. muciniphila is one of the inhabitant gut microbiota, which modulates 
expression of GPCRs, such as Gpr43.45 In a previous study, the presence of A. muciniphila 
was associated with alteration in functional genes related to host immune development 
in AD.11 The mucin degradation of A. muciniphila leads to generation of SCFAs, which is of 
help to the host and surrounding microbiome in gut.46 Conversely, the consumption of 
SCFAs is needed for the activity of A. muciniphila. Our current results suggest that reduction 
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in oxidative phosphorylation may be influenced by the increased levels of SCFAs in the gut 
through reduction in SCFAs consumption (Fig. 4 and 5C and D). Hence, the reduction in 
SCFAs levels in infants with transient AD group may be due to the use of SCFAs for remission. 
Therefore, a reduction in the gut composition of A. muciniphila, alteration in SCFAs and the 
oxidative phosphorylation levels, which may be associated with inflammatory responses and/
or energy-related metabolism, may play a role in the remission of AD in early life. Further 
studies are necessary to clarify these findings, including functional studies to elucidate the 
mechanisms mediated by Akkermansia.
Our study has several strengths of note. First, our study subjects were obtained from a 
previously established general population-based prospective cohort. Secondly, the AD 
phenotype, in terms of the natural course of this disorder, was assessed by pediatric 
allergists. Thirdly, this is the first study to reveal a difference in the gut microbiota 
composition, functions and stool SCFAs in relation to the natural course of AD. Finally, 
we analyzed stool samples from children that had not received antibiotics that could have 
affected the composition of the gut microbiota.
Our present study also had some limitations of note. The AD severity in our present series 
was mostly mild, as our subjects were sourced from a general population-based cohort. This 
reflects the low incidence of severe AD in infancy in the general population. Secondly, the 
sample size used in this analysis was relatively small, so we need to be careful to generalize 
these results. Thirdly, the human intestinal microbiota was comprised of bacteria, fungi and 
viruses, but we did not consider the roles for fungi and viruses. Further studies are necessary 
to resolve these limitations, including a replication study using most of our current subjects 
and functional studies to assess these phenomena mechanistically. It should also be noted 
that we analyzed the follow-up data regarding the progression of AD which was recorded by 
pediatric allergists from birth to 2 years of age and performed 16s rRNA sequencing as well as 
metagenome shotgun analysis of stool samples at 6 months.
In conclusion, an imbalance between gut Streptococcus, Clostridium and Akkermansia and a 
decrease in oxidative phosphorylation-related microbial functional genes may determine the 
natural course of AD in early life. SCFAs in the gut and decreased oxidative phosphorylation 
related to A. muciniphila in the gut microbiota were associated with the persistence of AD via 
energy supplementation to specific gut microbiota and via regulation of immune response. 
Our current findings suggest that the observed associations between the gut microbiome and 
persistent AD can be clinically useful in the prediction of AD persistence in early life.
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